|
GOLGA7 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.32969999958144E-08 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.26389998467147E-09 |
| Normal-vs-Stage2 |
1.945610E-02 |
| Normal-vs-Stage3 |
3.885000E-01 |
| Normal-vs-Stage4 |
2.570200E-01 |
| Stage1-vs-Stage2 |
1.160250E-01 |
| Stage1-vs-Stage3 |
3.813500E-04 |
| Stage1-vs-Stage4 |
1.058990E-01 |
| Stage2-vs-Stage3 |
2.028200E-01 |
| Stage2-vs-Stage4 |
7.033400E-01 |
| Stage3-vs-Stage4 |
5.509200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.36090000379951E-08 |
| Normal-vs-AfricanAmerican |
1.438590E-04 |
| Normal-vs-Asian |
1.363640E-01 |
| Caucasian-vs-AfricanAmerican |
2.879400E-01 |
| Caucasian-vs-Asian |
7.234600E-01 |
| AfricanAmerican-vs-Asian |
5.085400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.06730007848932E-10 |
| Normal-vs-Female |
7.782200E-03 |
| Male-vs-Female |
2.644800E-04 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
3.165300E-04 |
| Normal-vs-Extreme_Weight |
1.33799999968431E-08 |
| Normal-vs-Obese |
1.563330E-04 |
| Normal-vs-Extreme_Obese |
3.564500E-03 |
| Normal_Weight-vs-Extreme_Weight |
2.793000E-01 |
| Normal_Weight-vs-Obese |
7.890200E-01 |
| Normal_Weight-vs-Extreme_Obese |
2.328800E-01 |
| Extreme_Weight-vs-Obese |
1.259380E-01 |
| Extreme_Weight-vs-Extreme_Obese |
4.700800E-01 |
| Obese-vs-Extreme_Obese |
1.597990E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.245600E-01 |
| Normal-vs-Age(41-60Yrs) |
4.80049999995735E-06 |
| Normal-vs-Age(61-80Yrs) |
1.71070047016997E-10 |
| Normal-vs-Age(81-100Yrs) |
1.54538000000093E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.737640E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.427600E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.630300E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.044800E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.708810E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.955600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
7.24750037761623E-10 |
| Normal-VS-Type2 PRCC |
2.11790000004264E-06 |
| Normal-VS-KIRP CIMP |
1.196160E-01 |
| Normal-VS-Unclassified PRCC |
1.178260E-03 |
| Type1 PRCC-VS-Type2 PRCC |
2.584200E-01 |
| Type1 PRCC-VS-KIRP CIMP |
3.398200E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
2.440400E-01 |
| Type2 PRCC-VS-KIRP CIMP |
3.61370000000472E-05 |
| Type2 PRCC-VS-Unclassified PRCC |
8.030200E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
7.997800E-04 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.38510000000392E-06 |
| Normal-vs-N1 |
5.832600E-01 |
| Normal-vs-N2 |
1.880390E-01 |
| N0-vs-N1 |
7.795900E-03 |
| N0-vs-N2 |
4.835200E-01 |
| N1-vs-N2 |
5.806000E-01 |
|
|
